ACT AlzChem Group

EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Share Repurchase

EQS-News: Alzchem Group AG / Key word(s): Share Buyback
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Share Repurchase

29.11.2024 / 15:32 CET/CEST
The issuer is solely responsible for the content of this announcement.


 

 

 

Alzchem Group AG

 

 Disclosure

according to Article 5 of the EU Regulation 596/2014

and Article 2 Section (1) of the Delegated EU Regulation 2016/1052

 

Share Repurchase

 

 

Alzchem Group AG announces the start of the share repurchase program which was published by an ad hoc announcement dated November 5, 2024.

 

Starting December 2, 2024, Alzchem Group AG (hereinafter also referred to as the “Company”) will repurchase over a period of up to twelve months up to 100,000 no-par-value shares of the Company having a total purchase price of up to EUR 6 million (excluding ancillary purchase costs) exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA). The maximum purchase price per share (excluding ancillary purchase costs) will not exceed the share price determined by the opening auction in XETRA trading on the trading day by more than 10 per cent and it will not fall short of the share price by more than 20 per cent. The Managing Board of Alzchem Group AG, upon authorization of the Supervisory Board, is thus exercising the authorization by the Annual General Meeting on May 7, 2024, to acquire own shares.

 

The purpose of the buyback is (i) to acquire an acquisition currency, (ii) to issue the repurchased shares to employees of Alzchem Group or (iii) to redeem the shares. Other legally permissible purposes covered by the authorization of the Annual General Meeting are not excluded.

 

The repurchase program will be carried out on behalf and account of Alzchem Group AG through a bank, which was commissioned by the Company. The bank will decide on the timing of the share purchase independently and without being influenced by the Company. The share repurchase program may be suspended and resumed at any time, in line with applicable statutory regulations.

 

Regardless of the extended purposes the share repurchase program will be implemented pursuant to the trading terms of Art. 5 of the EU Regulation no 596/2014 and Art. 2 Sec. (1) of the Delegated EU Regulation no 2016/1052 (“DelReg”). Accordingly, executed repurchases will be announced in a manner compliant with the requirements of Art. 2 Sec. (3) DelReg no later than on the seventh trading day following their conclusion. In addition, Alzchem Group AG will provide regular updates on the progress of the share repurchase program at

 

 

Trostberg, November 29, 2024

 

 

Alzchem Group AG

-  Managing Board  -



29.11.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
Phone:
Fax:
E-mail:
Internet:
ISIN: DE000A2YNT30
WKN: A2YNT3
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart
EQS News ID: 2041541

 
End of News EQS News Service

2041541  29.11.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2041541&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
29/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AlzChem Group

Peter Thilo Hasler
  • Peter Thilo Hasler

Weiterhin mit robustem Gewinnwachstum

Nach wie vor ist die Ertragsentwicklung von Alzchem von konjunkturellen Herausforderungen geprägt, profitiert aber in ungleich stärkerem Maße von der Verschiebung des Umsatz-Mix in das hochmargige Segment Specialty Chemicals. Weil deshalb die vorgelegten Zahlen zum ersten Quartal 2025 erneut über unseren Schätzungen sowie den Consensus-Erwartungen lagen und wir davon ausgehen, dass die höhermargigen Potenziale weiterhin abgeschöpft werden können, heben wir unser aus einem dreiphasigen DCF-Entity...

 PRESS RELEASE

EQS-News: Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung...

EQS-News: Alzchem Group AG / Schlagwort(e): Aktienrückkauf/Aktienrückkauf Alzchem Group AG: Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052 - Zeitweilige Unterbrechung des Aktienrückkaufprogramms 17.03.2025 / 11:38 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Alzchem Group AG   Bekanntmachung nach Art. 5 der Verordnung (EU) 596/2014 und Art. 2 Abs. 1 der Delegierten Verordnung (EU) 2016/1052       Trostberg, 17. März 2025   Zeitweilige Unterbrechung de...

 PRESS RELEASE

EQS-News: Alzchem Group AG: Disclosure according to Article 5 of the ...

EQS-News: Alzchem Group AG / Key word(s): Share Buyback/Share Buyback Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Temporary Interruption of Share Repurchase Prog 17.03.2025 / 11:38 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG   Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052     Trostberg, March 17, 2025   Temporary Inter...

Peter Thilo Hasler
  • Peter Thilo Hasler

Von hohem Niveau aus weiter aufwärts

Dass Alzchem auch im vierten Quartal 2024 sowohl die eigene Guidance als auch alle Consensus-Prognosen übertraf, kann aus unserer Sicht nicht als Normalität eingestuft werden. Kritisch ließe sich einwenden, dass die Luft angesichts des inzwischen erreichten Margenniveaus dünner wird, doch lässt die anhaltende Verschiebung zum höhermargigen Segment Specialty Chemicals nach unserer Auffassung einen erneuten Margenanstieg und einen damit einhergehenden überproportionalen Ergebnisanstieg auch im Ges...

 PRESS RELEASE

EQS-News: Alzchem Group AG achieves record EBITDA of EUR 105.3 million...

EQS-News: Alzchem Group AG / Key word(s): Annual Results/Annual Report Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 28.02.2025 / 06:55 CET/CEST The issuer is solely responsible for the content of this announcement. Alzchem Group AG achieves record EBITDA of EUR 105.3 million (+29.4%) in fiscal year 2024 Free cash flow climbs significantly by 42.3% to EUR 74.2 million Dividend to be increased by 50% from EUR 1.20 to EUR 1.80 Further sales and EBITDA growth forecast for 2025 Trostberg, February 28, 2025 – Alzchem Group AG, a ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch